Search

Search Results
Results 4781 - 4790 of 4863 for multiple sclerosis
  • Drug - 27 Aug 2026
    Consumer Medicine Information (CMI) about Diabex XR 500 and 1000 intended for persons living in Australia.
  • Drug - 27 Aug 2026
    Consumer Medicine Information (CMI) about Diabex intended for persons living in Australia.
  • Drug - 27 Aug 2026
    Consumer Medicine Information (CMI) about Cavstat intended for persons living in Australia.
  • Drug - 30 Jun 2026
    Consumer Medicine Information (CMI) about Simponi intended for persons living in Australia.
  • Drug - 18 Jun 2026
    Consumer Medicine Information (CMI) about Diaformin (AF) intended for persons living in Australia.
  • Drug - 1 Jun 2026
    Consumer Medicine Information (CMI) about Itracap intended for persons living in Australia.
  • White Paper - 29 May 2026
    BD-pTau 217 is a refined biomarker which enhances Alzheimer’s specificity while retaining the strengths of plasma pTau 217.
  • Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Prodeinextra intended for persons living in Australia.
  • Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Prodeine intended for persons living in Australia.
  • Drug - 28 May 2026
    Consumer Medicine Information (CMI) about Prodeine Forte intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.